反应详情

温度

100 °C

In a microwave vial methyl 2-((S)-6-((R)-7-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-1-yloxy)-2,3-dihydrobenzofuran-3-yl)acetate (500 mg), 3-((4-bromo-3,5-dimethylphenoxy)methyl)-3-methyloxetane (450 mg), K3PO4 (450 mg) are suspended in toluene (2.5 mL) and water (250 μL) and purged for 10 minutes with argon. Palladium-(II)-acetate (12 mg) and dicyclohexyl(2′,6′-dimethoxybiphenyl-2-yl)phosphine (S-Phos) (44 mg) are added, the vial is sealed and the mixture is stirred at 100° C. for 4 hours. After cooling to room temperature the mixture is partitioned between diethylether and saturated aqueous NH4Cl solution. The organic phase is dried (MgSO4) and concentrated. The residue is chromatographed on silica gel (cyclohexane/ethyl acetate 90:10→60:40) to give the title compound. Yield: 420 mg; LC (method 4): tR=1.93 min; Mass spectrum (ESI+): m/z=569 [M+Na]+.

1. customwater (250 μL) and purged for 10 minutes with argon
2. additionPalladium-(II)-acetate (12 mg) and dicyclohexyl(2′,6′-dimethoxybiphenyl-2-yl)phosphine (S-Phos) (44 mg) are added
3. customthe vial is sealed
4. temperatureAfter cooling to room temperature the mixture
5. customis partitioned between diethylether and saturated aqueous NH4Cl solution
6. dry with materialThe organic phase is dried (MgSO4)
7. concentrationconcentrated
8. customThe residue is chromatographed on silica gel (cyclohexane/ethyl acetate 90:10→60:40)